Prospera Financial Services’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-103
Closed -$9K 1625
2022
Q2
$9K Hold
103
﹤0.01% 1374
2022
Q1
$16K Buy
+103
New +$16K ﹤0.01% 1848